<?xml version="1.0" encoding="UTF-8"?>
<p>Following the identification of COVID-19, the WHO published a list of protocols used by public health and specialist research labs for identification of SARS-CoV-2 [
 <xref rid="B85-microorganisms-08-01228" ref-type="bibr">85</xref>]. In addition, also due to shortcomings of RT-PCR approach to detect SARS-CoV-2, the serum immunoglobulin (Ig) anti-SARS-CoV-2 type M (IgM)/IgG antibody detection against the SARS-CoV-2 internal nucleoprotein (NP) and surface spike protein receptor-binding domain (RBD) may be used in diagnosis of COVID-19 and to monitor the disease stages and identify past infection and immunity [
 <xref rid="B83-microorganisms-08-01228" ref-type="bibr">83</xref>,
 <xref rid="B86-microorganisms-08-01228" ref-type="bibr">86</xref>].
</p>
